Live Breaking News & Updates on Hualan Biological Bacterin Co Ltd

Russian fund to increase Sputnik V production with China s company
Russian fund to increase Sputnik V production with China s company
Moscow, Apr 19 (Prensa Latina) The Russian Direct Investment Fund (RDIF) on Monday announced the cooperated production of more than 100 million doses a year of the Sputnik V vaccine in conjunction with Chinese company Hualan Biological Bacterin Co Ltd.
The manufacture of the Covid-19 vaccine will be carried out in the Chinese facilities of that company and will be used to immunize more than 50 million people, the Public Relations service of the Russian Fund pointed out. By late March, China s Shenzhen Yuanxing Gene-tech Co. also agreed to produce 60 million doses of the Sputnik V vaccine to fight the SARS-CoV-2 coronavirus, which causes the disease, in conjunction with the RDIF, which financed the development of the medicine. ....

Kirill Dmitriev , Temas Relacionados , Hualan Biological Bacterin Co Ltd , Russian Fund , China Shenzhen Yuanxing Co , Russian Direct Investment Fund , Prensa Latina , Public Relations , Shenzhen Yuanxing Gene Tech , Hualan Biological Bacterin , Executive Kirill Dmitriev , Sputnik V , ரஷ்ய நிதி , ரஷ்ய நேரடி முதலீடு நிதி , ப்ரெந்ஸ லத்தீன் , பொது உறவுகள் ,